Product
Supplier
Encyclopedia
Inquiry
Home > Biochemical Engineering > Polypeptide > Tirzepatide for Sale > high purity Lyophilized Powder weight loss peptide Tirzepatide
high purity Lyophilized Powder weight loss peptide Tirzepatide buy - large image1
high purity Lyophilized Powder weight loss peptide Tirzepatide buy - image1
high purity Lyophilized Powder weight loss peptide Tirzepatide buy - image2
high purity Lyophilized Powder weight loss peptide Tirzepatide buy - image3
high purity Lyophilized Powder weight loss peptide Tirzepatide buy - image4
high purity Lyophilized Powder weight loss peptide Tirzepatide buy - image5
high purity Lyophilized Powder weight loss peptide Tirzepatide buy - image6

high purity Lyophilized Powder weight loss peptide Tirzepatide

2025 Inquiries

Unit Price:

$71/MT FOB

Get Latest Price
CAS No.:

2023788-19-2

Grade:

Industrial Grade

Content:

99%

Port:

HongKong

Brand:

KangTai

Packaging:

20mg/vial,10vials/kits

Price valid (until):

2026-08-27

Company Type:
Trader
Location:
China
Qualification:
Main Products:

Polypeptide

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


    sales manager:Estella 
    Whatsapp:+447563862140 
    email:2806946916@qq.com 

    Sincerely look forward to your inquiries about our products.


    Action Mechanism

    Tirzepatide is a novel unimolecular dual agonist of Glucagon-Like Peptide‑1 Receptor (GLP‑1R) and Glucose-Dependent Insulinotropic Polypeptide Receptor (GIPR).
    1. 1.Activate GLP‑1R: Promote glucose-dependent insulin secretion, suppress glucagon release, slow gastric emptying, reduce appetite and food intake;
    2. 2.Activate GIPR: Further improve pancreatic beta cell function, enhance insulin sensitivity, coordinate with GLP‑1 pathway to regulate energy metabolism and body weight.
    Different from single-target GLP‑1 analogues, dual receptor activation produces synergistic effects on glycemic control and metabolism regulation. The PEG linker modification improves protease resistance, prolongs circulating half-life in experimental models.



     Core Features

    1. 1.Dual GLP‑1R / GIPR agonist: Unique dual-target mechanism, widely used for comparative metabolism research versus single-target GLP‑1 peptides.
    2. 2.PEG modified structure: Optimized metabolic stability, longer duration of action in animal studies.
    3. 3.Glucose-dependent insulinotropic activity: Lower risk of hypoglycemia compared with non-glucose-dependent insulin secretagogues.
    4. 4.Multiple research directions: Applicable to glycometabolism, insulin resistance, obesity, hepatic lipid metabolism related mechanism exploration.
    5. 5.Solubility: Soluble in weak acid aqueous solution and suitable biological buffer. Avoid strong alkaline environment.
    Items Specifications






    Shop high purity Lyophilized Powder weight loss peptide Tirzepatide-Detailed Image 1
    Shop high purity Lyophilized Powder weight loss peptide Tirzepatide-Detailed Image 2
    Shop high purity Lyophilized Powder weight loss peptide Tirzepatide-Detailed Image 3
    Shop high purity Lyophilized Powder weight loss peptide Tirzepatide-Detailed Image 4
    Shop high purity Lyophilized Powder weight loss peptide Tirzepatide-Detailed Image 5
    Shop high purity Lyophilized Powder weight loss peptide Tirzepatide-Detailed Image 6

    Kangtai focuses on the research, solid-phase synthesis, purification and standardized supply of research-grade synthetic peptides. We are equipped with professional peptide synthesis laboratories, standardized production workshops and comprehensive full-process quality control systems. We have accumulated mature technical experience in peptide synthesis process optimization, impurity separation and strict quality control, and are familiar with international testing standards and supply specifications for research peptides.


    We supply high-purity peptide raw materials to university laboratories, biotech research institutes, pharmaceutical R&D teams and global peptide distributors. We adhere to stable purity, authentic batch test data and standardized delivery standards. We can provide comprehensive technical support including dissolution guidance, stability research, experimental reference schemes and supporting documents. Supported by a complete supply chain system, we guarantee continuous stable supply and support sample trial orders. All batches implement standardized quality management, and official COA test reports can be provided to ensure raw material authenticity and consistent purity.Shop high purity Lyophilized Powder weight loss peptide Tirzepatide-Detailed Image 7 Shop high purity Lyophilized Powder weight loss peptide Tirzepatide-Detailed Image 8 Shop high purity Lyophilized Powder weight loss peptide Tirzepatide-Detailed Image 9 Shop high purity Lyophilized Powder weight loss peptide Tirzepatide-Detailed Image 10 Shop high purity Lyophilized Powder weight loss peptide Tirzepatide-Detailed Image 11

    We have cooperated with experienced shipping forwarders for many years, they arrange the shipment. No matter by express, by air or by sea, we will track the course of the goods all the way, to make sure goods arrive at you on time and in good condition.

    ECHEMI Editorial Reference

    Tirzepatide (LY3298176) was developed as a dual agonist to both GLP-1 and gastric inhibitory polypeptide (GIP) receptors (Frias et al., 2018). Similar to GLP-1, GIP is an incretin hormone that functions to induce insulin secretion.

    Basic Info
    Product Name:

    Tirzepatide

    Other Name:

    LY3298176;

    CAS No.:

    2023788-19-2

    Molecular Formula:

    C225H348N48O68

    Molecular Weight:

    4813

    EC Number:

    200-001-8

    Categories:

    Polypeptide

    Characteristics
    Appearance:

    White to off-white

    Research
    Class:

    Dual agonist — GIPR, GLP-1R

    Status:

    FDA-approved (Mounjaro / Zepbound)

    Mechanism:

    Dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. A 39-amino-acid modified peptide with a C20 fatty diacid moiety that enables albumin binding for extended half-life (~5 days). Selectively activates both GIPR and GLP-1R signaling pathways.

    EC50 (Human GLP1R):

    0.934 nM

    EC50 (Human GIPR):

    0.0224 nM

    Source:

    Frias JP, et al. N Engl J Med. 2021;385(6):503-515.DOI

    FDA:

    Mounjaro, Zepbound (approved 2022-05-13)

    References
    ChEMBL:

    CHEMBL4297839

    DrugBank:

    DB15171

    KEGG DRUG:

    D11360

    PubChem:

    PubChem

    Disclaimer:

    Tirzepatide is approved as a prescription medicine (Mounjaro, Zepbound) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Polypeptide

    Location:

    Room 205-E742, Building F, No. 53 Congyun Road, Huangshi Street, Baiyun District, Guangzhou City

    Average lead Time:

    15

    Total Annual Revenue:

    Less than $1 million

    Total Employees:

    5-10

    Year of Establishment:

    2026

  • Inquiry History
    2025 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    2023788-19-2 in unlabeled vials 10, 15 and 30 mg

    10  Feb 14, 2024
    United States

    Peptide drug GLP-1 Agonists Tirzepatide CAS 2023788-19-2 Weight loss 399 Inquiries

    10 MG Apr 3, 2024
    United States

    Tirzepatide Raw Powder Weight Loss Peptides CAS No 2023788-19-2 Tirzepatide Injection Peptides

    2 MT Dec 13, 2025
    Hongkong, China

    2023788-19-2

    1 KG Aug 13, 2026
    Germany

    2023788-19-2

    1 MG Jun 18, 2026
    United States

    2023788-19-2 Retatrutide

    1 G Sep 22, 2023
    United States

    2023788-19-2 Trizepatide

    10 MT Oct 29, 2023
    United States

    Tirzepatide 2023788-19-2

    Feb 19, 2024
    United States

    Tirzepatide 2023788-19-2

    10 G Oct 31, 2023
    United States

    Trizepatide 2023788-19-2 Raw Material LY3298176 Tirzepatide powder

    Dec 2, 2025
    United States

    Fat Burning Peptides Tirzepatide 10mg/Vial 15mg/Vial Tirzepatide CAS: 2023788-19-2

    1 MT Jan 25, 2024
    United States

    Pharmacy Grade CAS 2023788-19-2 Tirzepatide 99% White powder Tirzepatide

    1 MT Oct 20, 2023
    United States

    Peptide drug GLP-1 Agonists Tirzepatide CAS 2023788-19-2 Weight loss

    2 KG Oct 20, 2023
    United States

    Pharmacy Grade CAS 2023788-19-2 Tirzepatide 99% White powder Tirzepatide

    50  Aug 17, 2023
    United States

    supply Tirzepatide Safe Material Shipping Trizepatide 2023788-19-2 Raw Tirzepatide powder

    10 MG Apr 4, 2024
    United States

    COA Offer Top quality Weight Loss Peptides Tirzepatide 10mg/vial GLP-1 2023788-19-2

    1 MT Sep 10, 2023
    Kenya

    Janoshik Test Tirzepatide 99% White powder High Quality Tirzepatide Weight loss CAS 2023788-19-2

    30 MG Dec 26, 2025
    United States

    Ex-factory price tirzepatide T30 10vials 30mg kit cas 2023788-19-2 for weight loss peptide

    10  Dec 30, 2024
    United Kingdom

    Manufacturer supply high quality hot sale lowest price Tirzepatide CAS NO,2023788-19-2 99% powder 2023788-19-2 Claire

    100 G Nov 4, 2023
    Canada

    99.9% Purity GLP-1 Injection Weight Loss Peptides Liraglutide Retatrutide Tirzepatide Semaglutide 5mg 10mg CAS 2023788-19-2

    2 MT Oct 22, 2023
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.